LumiMeds Review

LumiMeds in one line: a rock-bottom flat rate for compounded GLP-1s

LumiMeds is a telehealth provider built around a single, blunt promise: one flat monthly price for compounded semaglutide or tirzepatide, no matter what dose you climb to. At $133 a month it sits well under the category median of $170, and the whole pitch is aimed at people who want the cheapest legitimate path onto a GLP-1 without decoding a pricing ladder. If you're price-shopping and you don't need a brand-name pen, LumiMeds is squarely worth a look.

How the flat-rate plan actually works

Most telehealth GLP-1 programs raise your bill as your dose increases, so the friendly intro number quietly doubles by month three. LumiMeds does the opposite. Its own site states it plainly: 'Fixed prices, no matter your dosage. No hidden fees.' You're billed on a three-month plan, and the dose you titrate up to doesn't change what you pay. That's the single most useful thing to understand here — the $133 figure is meant to be the real, all-in number, not a teaser that resets later.

One honest caveat on the price: LumiMeds doesn't run a separate first-month promo rate, so don't go looking for a discounted trial month — the flat rate is the deal. We also found minor drift between the published semaglutide and tirzepatide numbers during verification, so confirm the exact figure for your specific medication at checkout before you commit.

What you're actually paying for

The flat fee is bundled, not just the drug. According to the provider, the plan includes an initial telehealth visit, real-time physician support, your prescription plus the medication itself, and remote monthly check-ins. In plain terms: the consult and the medicine are rolled into one price, so you're not getting surprised by a separate visit charge on top.

• Initial telehealth visit to get evaluated and prescribed
• Real-time physician support rather than a one-and-done intake
• Prescription and medication included in the flat monthly fee
• Remote monthly check-ins to keep titration on track

The medications: compounded only

LumiMeds dispenses compounded semaglutide and compounded tirzepatide — the same active molecules found in Ozempic, Wegovy, Mounjaro and Zepbound, but made by a compounding pharmacy rather than the brand manufacturer. There is no brand-name pen option here, and no oral version. That's the trade that makes the low price possible. Compounded GLP-1s can be a sensible route for cash-pay patients, but they aren't FDA-reviewed the way brand products are, so go in understanding you're choosing the compounded lane on purpose.

Why the low price is realistic, not a red flag

A flat rate this far below the median usually invites suspicion, but the math is straightforward: cut out the brand markup, deliver care entirely over telehealth, and bundle everything into one recurring plan. That's a legitimate cost structure, not a gimmick. The thing you give up for it is optionality — no brand pens, no oral tablets, just the two compounded injectables.

Where LumiMeds is thin: transparency and coverage

This is the provider's real weak spot, and it's worth being blunt about. LumiMeds does not publish its full list of available states. Its site notes that 'exclusions may apply based on prescribed medication and state of residence,' with specific provider-group restrictions called out in DC and South Carolina. So the only reliable way to know whether you can actually be treated — and with which drug — is to start the intake and see what it offers you. For a category where state availability makes or breaks the whole thing, that lack of an upfront map is a genuine friction point.

Beyond geography, program details are simply lighter than what the most transparent competitors put on the table. You won't find a named compounding-pharmacy partner with posted accreditation, and the finer print on refunds, guarantees and cancellation isn't spelled out publicly. None of that is disqualifying, but it means you're trusting more and verifying less than you would with a provider that lays everything out.

Who should choose it — and who should skip it

Choose LumiMeds if your top priority is the lowest believable monthly cost on a compounded GLP-1, you're comfortable with a fully online, compounded-only model, and you don't mind running the intake to confirm your state. The flat-rate structure is especially friendly if you expect to titrate to a higher dose, since that's exactly where dose-based plans get expensive.

Skip it if you want a brand-name pen, an oral option, a published state list before you hand over any information, or a provider that documents its pharmacy partner and refund terms in detail. Buyers who value paperwork and predictability over the last few dollars of savings will be happier elsewhere.

Trust and safety: clean record, light disclosure

On the reassuring side, LumiMeds carries no FDA warning letters in our records, and the plan does include real-time physician support plus monthly check-ins rather than a fire-and-forget prescription. On the cautious side, our confidence is capped by how little the provider discloses — no named accredited compounding partner and no public state roster. We rate the medical model as reasonable but the transparency as below the leaders. See our scoring methodology for how we weigh these factors.

Bottom line

LumiMeds is one of the most aggressive flat-rate deals in compounded GLP-1 telehealth: $133 a month, dose-proof, with the consult and medication bundled in. The price and the no-surprise titration are the real draw. The cost of that simplicity is thin public disclosure — undisclosed states, restrictions in DC and South Carolina, and no documented pharmacy partner. If you want cheap, compounded, and don't mind doing a little verifying yourself, it's a strong pick. If you want a brand pen or full transparency before you sign up, look further down the rankings.

If you're weighing alternatives, Oak ($130/month) and bmiMD ($99/month) are among the closest options we track to LumiMeds.